Results 171 to 180 of about 117,898 (292)

Acute kidney injury and delayed methotrexate clearance in an adult patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia treated with imatinib [PDF]

, 2023
Chen Chen, Qi Jian, Xia Li, Wang Yong-jing   +3 more
openalex   +1 more source

Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation

Small Science, Volume 6, Issue 1, January 2026.
Tregs control immune tolerance but can also enable tumor escape. Nanomaterials can now expand or stabilize Tregs to treat autoimmunity and support transplantation or conversely disrupt tumor Tregs to boost antitumor immunity. We also discuss unintended Treg modulation by nanoparticles, safety and manufacturing challenges, and future translational ...
Yiyin Chen, Haibo Huang, Xiang Wang, Xinghao Yu, Ziyan Huang, Zhou Jin, Chen Chen, Yan Chen, Bruce R. Blazar, Yang Xu, Yunjie Lu   +10 more
wiley   +1 more source

Senolytic Treatment With Dasatinib and Quercetin Reshapes Influenza‐Specific CD8 T Cell Responses During Infection in Aged, Vaccinated Mice

Aging Cell, Volume 25, Issue 1, January 2026.
Impaired vaccination responses leave older adults more vulnerable to severe influenza (flu) infections. Pretreatment with senolytic Dasatinib and Quercertin (D + Q) did not improve vaccine responses but altered some responses to sublethal flu challenge. Despite these changes, overall flu outcomes were not impacted.
Andreia N. Cadar, Blake L. Torrance, Sofie A. Fischler, Darlene A. Djaba, Zena Haddad, Dominique E. Teskey, Nagaraju Marka, Kelsey A. Gorgei, Erica C. Lorenzo, Laura Haynes, Jenna M. Bartley   +10 more
wiley   +1 more source

Imatinib-induced rhabdomyolysis: A case report. [PDF]

Leuk Res Rep
Rubenstein J, Schwartz SM, Vankawala J, Caplan M, Shea S, Jurcic JG.   +5 more
europepmc   +1 more source

Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines

, 2018
Valeria Sorrenti, Valeria Pittalà, Giuseppe Romeo, Emanuele Amata, Maria Dichiara, Agostino Marrazzo, Rita Turnaturi, Orazio Prezzavento, Ignazio Barbagallo, Luca Vanella, Antonio Rescifina, Giuseppe Floresta, Daniele Tibullo, Francesco Di Raimondo, Sebastiano Intagliata, Loredana Salerno   +15 more
openalex   +1 more source

Data from Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing β-Catenin Signaling

, 2023
Bei Jin, Ke Ding, Jingxuan Pan
openalex   +1 more source

A critical review of management of allogeneic transplant‐eligible adults with Ph+ acute lymphoblastic leukaemia

British Journal of Haematology, Volume 208, Issue 1, Page 39-53, January 2026.
Proposed management of newly diagnosed Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukaemia (ALL) in transplant‐eligible patients. Suggested considerations when deciding the treatment pathway available to a newly diagnosed Ph+ ALL patient that would be deemed transplant eligible. Summary Acute lymphoblastic leukaemia (ALL) in 20%–30% of
Naranie Shanmuganathan, Andrew Grigg
wiley   +1 more source

Comparative Analysis of a Dual DNA–RNA Panel and a DNA‐Only Panel for Sarcoma: Real‐World Data From a Nationwide Genomic Database

Cancer Science, Volume 117, Issue 1, Page 156-168, January 2026.
Dual DNA–RNA panel with matched tumor–normal testing may improve diagnostic accuracy and inform treatment decisions in the routine clinical management of sarcoma. ABSTRACT Next‐generation sequencing‐based comprehensive cancer genomic profiling is promising in cancer management; however, most studies rely on tumor‐only DNA panels from single ...
Eiji Nakata, Kiichiro Ninomiya, Tatsunori Osone, Daisuke Ennishi, Shuta Tomida, Tomohiro Fujiwara, Toshiyuki Kunisada, Mashu Futagawa, Akira Hirasawa, Shinichi Toyooka, Toshifumi Ozaki   +10 more
wiley   +1 more source

Supplemental Table S1 from The Tyrosine Kinase Inhibitor Imatinib Augments Extracellular Fluid Exchange and Reduces Average Collagen Fibril Diameter in Experimental Carcinoma

, 2023
P. Olof Olsson, Renata Gustafsson, René in ‘t Zandt, Tomas Friman, Marco Maccarana, Emil Tykesson, Åke Oldberg, Kristofer Rubin, Sebastian Kalamajski   +8 more
openalex   +1 more source

Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells. [PDF]

Hematol Transfus Cell Ther
Avinery L, Regev D, Khamaisi H, Gopas J, Mahajna J.   +4 more
europepmc   +1 more source